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INTRODUCTION
Carbazoles consist of a tricyclic nucleus with two benzene rings flanking a pyrrole ring. Most of the known naturally occurring carbazole alkaloids contain an annulated ring or ring system in both benzene rings and were isolated from higher plants and fungi, which display a broad range of biological properties such as anticancer, antibacterial, antiviral, and antiplasmodial activities (Knö lker and Reddy, 2002) . At present, the biosynthesis of plant carbazole metabolites is not fully understood (Schmidt et al., 2012) . The most widely accepted hypothesis is that the nucleus of carbazole alkaloids from higher plants may derive from anthranilic acids and prenyl pyrophosphate (Schmidt et al., 2012) .
In contrast to widespread carbazole alkaloids from higher plants and fungi, bacterial carbazole metabolites are much less common. The first class of bacterial carbazoles are indolo [2,3-a] pyrrolo [3,4-c] carbazoles, representatives of which include staurosporine (Meksuriyen and Cordell, 1988) and rebeccamycin (Pearce et al., 1988) , and the second class are indolosesequiterpenes, representatives of which are oridamycins (Takada et al., 2010) and xiamycins (Ding et al., 2010 (Ding et al., , 2011 . The bio-origins of both types of carbazole-containing metabolites have been well established in the last decade (Howard-Jones and Walsh, 2006; Xu et al., 2012; Li et al., 2012 Li et al., , 2015 Baunach et al., 2015) . The third type of carbazoles, however, consist of a simple tricyclic ring system with aliphatic side chains, including carquinostatins, carazostatin, carbazoquinocins, carbazomycin, (S)-streptoverticillin, and neocarazostatins (Feng et al., 2007; Kato et al., 1989 Kato et al., , 1991 Ruanpanun et al., 2011; Sakano and Nakamura, 1980; Shin-ya et al., 1993 Shin-ya et al., , 1997 Tanaka et al., 1995) (Figure 1 ). Generally this group of bacterial carbazoles can act as free radical scavengers and exhibit potent neuronal cell-protecting activity (Schmidt et al., 2012) . Free radicals play a key role in the initiation of a variety of diseases such as cerebral and myocardial ischemia, arteriosclerosis, inflammation, rheumatism, and cancer. Antioxidants, acting as free radical scavengers, can act as protecting substances against damage caused by free radicals (Palinski et al., 1989) . In this respect, free radical scavenging compounds are being extensively investigated as potential drug leads (Schmidt et al., 2012) . Due to their pharmacological potential as cell-protecting agents, there has been considerable interest among medicinal chemists to develop this class of molecules (Choshi et al., 1997; Czerwonka et al., 2006; Rawat and Wulff, 2004; Shin-ya and Ogasawara, 1996) . The biosynthetic pathways of this group of bacterial carbazoles have not been reported, although feeding experiments confirmed that L-tryptophan, pyruvate, and acetate provide the carbazole nucleus (Kaneda et al., 1990; Orihara et al., 1997; Yamasaki et al., 1983) (Figure S1A ).
In our screening program to discover novel natural products from the soil bacterium Streptomyces sp. MA37 (Deng et al., 2014; Huang et al., 2015; Ma et al., 2015) , neocarazostatin A 1 was isolated from this strain (Figures S1B-S1G). Neocarazostatins A-C ( Figure 1 ) were originally discovered from the culture of Streptomyces sp. GP38 in 1991 (Kato et al., 1991) . The neocarazostatins exhibited a strong inhibitory effect on the free radicalinduced lipid peroxidation in rat brain homogenate. The IC 50 values of the neocarazostatins for inhibition of lipid peroxidation were considerably lower than those of the free radical scavenger butylhydroxytoluene and the brain-protective agent flunarizine (Kato et al., 1991) .
In this study, we report the actinobacterial biosynthetic gene cluster for the biosynthesis of NZS. Two enzymes, NzsA and NzsG, were biochemically characterized. NzsA is a P450 hydroxylase and NzsG is a phytoene-synthase-like (PSL) prenyltransferase, a PSL protein that catalyzes the prenylation of carbazole. Finally, we reconstituted in vitro the last two steps of the pathway to NZS using purified recombinant enzymes.
RESULTS
Identification of the nzs Gene Cluster NZS 1 possesses a prenyl group at C-6 on the indole ring. Initially, a homolog search of bacterial indole prenyltransferases was conducted. IptA from Streptomyces sp. SN-593 has been shown to be a 6-dimethyl-allyl (DMAL)-L-tryptophan synthase which is involved in the biosynthesis of 6-DMAL-3-carbaldehyde (Takahashi et al., 2010) . Although IptA homologs appeared to be widely spread in the Streptomyces genome, to our surprise, a BLAST (Basic Local Alignment Search Tool) search of the annotated genome of MA37 in the RAST server (Aziz et al., 2008) yielded no open reading frames (ORFs) with any obvious sequence identity to IptA in MA37.
Previous labeling studies established that indole pyruvate originating from L-tryptophan is likely to contribute rings B and C plus the intact C2 unit of C-3 and C-4 of ring A in the biosynthesis of carquinostatin B 3b ( Figure S1A ) (Kato et al., 1991) , a structurally close analog of 1 (Figure 1 ). The incorporation of pyruvate in secondary metabolism can also be observed in the biosynthesis of sugars containing a two-carbon branched chain, such as antibiotic natural products, yersiniose A from the Gramnegative bacterium Yersinia pseudotuberculosis (Chen et al., 1998) , aldgamycin E from Saccharothrix SA 103 (Ellestad et al., 1967) , and presumably tianchimycin B from Saccharothrix xinjiangensis (Wang et al., 2013 ). An in vitro assay indicated that the gene product YerE is a thiamine pyrophosphate (ThDP)-dependent enzyme, responsible for the C-C bond formation between 3-ketosugar and pyruvate during the biosynthesis of yersiniose A (Chen et al., 1998; Lehwald et al., 2010) . We performed a homolog search of YerE in MA37, resulting in identification of an ORF, annotated as a ThDP-dependent enzyme (NzsH) ( Figure 2A and Table 1 ), which shows moderate sequence identity (27%) to YerE.
Analysis of the genes in close proximity of nzsH allowed us to retrieve a candidate gene cluster (nzs) spanning approximately 17.8 kb ( Figure 2A and Table 1 ). The nzs cluster possesses ten ORFs, nine of which (NzsA-H and J) can be assigned catalytic functions (Table 1) . A BLAST search of NzsI indicated that it belongs to a small group of hypothetical proteins with no obvious catalytic function. Genes beyond this region are highly conserved in the chromosomes of other non-NZS producing Streptomyces strains such as Streptomyces griseus, Streptomyces avermitilis, and Streptomyces coelicolor ( Figure S2A ). Thus, we propose that these ten orfs define the boundaries of the nzs cluster.
In Vivo Experiments Confirmed that the Candidate Gene Cluster Directs the Biosynthesis of NZS 1 To confirm the identity of the nzs cluster we performed gene disruption, and ten different mutants (DnzsA-J) were generated ( Figures S2B-S2L ). High-performance liquid chromatography (HPLC) analysis of the extracts from these mutants demonstrated that inactivation of nzsE, F and nzsH-J completely abolished the NZS production ( Figure 2B ), suggesting that these five ORFs are essential for the biosynthesis of 1. Inactivation of nzsB-D, encoding anthranilate phosphoribosyltransferase, isopentenyl diphosphate (IPP) isomerase, and aromatic aminotransferase, respectively, resulted in only slightly decreased production of 1 ( Figure 2B 5-8 ). In accordance with these findings, bioinformatics analyses of the draft genome sequence of the MA37 revealed the presence of several other gene copies with predicted functions similar to NzsB-D, suggesting the cross-complementation roles played by these genes.
Gene disruption of nzsG completely abolished the production of 1 but resulted in accumulation of two new metabolites in the culture of the DnzsG mutant ( Figure 2B 4) . Subsequently, fermentation and chemical isolation afforded two pure compounds, 4 (7 mg) and 5 (4.3 mg) (Figure 3 ). The structures of 4 and 5 were established by the inspection of high-resolution (Tables  S4 and S5 ; Figures S3A-S3F , and S3M-S3R). Although compound 4 has chemical shifts in NMR spectra identical to the known carbazole metabolite, (S)-streptoverticillin, comparison of the values of the optical rotation of 4 with the ones of (S)-streptoverticillin and its non-natural enantiomer (R)-streptoverticillin (Thomas et al., 2011) indicated that 4 actually is (R)-streptoverticillin. Compound 5 is a new carbazole intermediate, which was named as precarazostatin. Both 4 and 5 lack prenyl substitution at C-6, suggesting that NzsG may be responsible for the prenylation at C-6 of the carbazole nucleus.
HPLC analysis also showed that, while the production of 1 was lost in the culture of the DnzsA mutant, two new metabolites, 2 and 6, were accumulated ( Figure 2B 2). Fermentation and isolation, followed by analyses of HR-ESIMS and 1D and 2D NMR spectral and optical rotation data, established that one metabolite is a known carbazole metabolite, neocarazostatin B 2 (Figures 3 and S3G-S3R), a close derivative of 1, suggesting that NzsA may be responsible for the installation of the hydroxyl group at C-11 of 2 to generate 1. The structure of compound 6 was determined as a new epoxy derivative of 2 on the basis of HR-ESIMS and 1D and 2D NMR analyses, which clearly indicated the replacement of D 16,17 in 2 with an epoxy ring (Figures 3, S3S-S3X).
Biochemical Assay Demonstrated that NzsG Is a New Prenyltransferase that Specifically Acts on 5
Given that 4 and 5 are not further metabolized in the DnzsG mutant, it was envisaged that they may be immediate substrates of NzsG. Bioinformatics analysis revealed that NzsG shares high sequence identity (60%-65%) with only three hypothetical proteins from Streptomyces but has 25%-40% similarity to a large family of putative phytoene synthases from actinomycetes. It also possesses a characteristic DDxxD motif, which is essential for binding prenyl diphosphate via metal ions (Liang et al., 2002 ). However, NzsG shows no homology to the identified bacterial or fungi aromatic or indole PTases. Further phylogenetic analysis indicated that NzsG forms the same branch with phytoene synthases instead of all of the known aromatic or indole PTases ( Figure S4A ), implying that NzsG may be a new type of emerging PTase family.
To determine the exact function of NzsG, we carried out a biochemical study. Overexpression of nzsG in Escherichia coli allowed isolation and purification of its encoded protein. The resultant NzsG appeared on SDS-PAGE with an estimated molecular weight of 38.1 kDa ( Figure S4B ) ( Figures S4D-S4F ). There was no turnover when NzsG was incubated with DMAPP, farnesyl pyrophosphate, indole derivatives (e.g. L-tryptophan, indole 3-pyruvate), or other tricyclic molecules (e.g. carbazole, acridine, fluorene, phenazine and dibenzothiophene, Figures 4, S4G-S4H), suggesting that NzsG has restricted substrate specificity. It has been demonstrated that some fungal indole PTases possess substrate promiscuity and can be used to prenylate larger aromatic ring systems, i.e. indolocarbazoles, using a chemoenzymatic approach (Yu et al., 2012) . NzsG, however, is the first native carbazole PTase reported, and belongs to a new subgroup of aromatic PTases.
Biochemical Assay Demonstrated that NzsA Is a P450 Hydroxylase Enzyme Overexpression of nzsA in E. coli allowed isolation and purification of a soluble protein with an estimated molecular weight of 46.0 kDa, as observed in SDS-PAGE ( Figure S5A ). Carbon monoxide binding assay on NzsA monitored by UV spectroscopy demonstrated that NzsA is indeed a P450 enzyme ( Figure S5B ) (Meunier et al., 2004) . In vitro experiments showed that the recombinant enzyme efficiently converted 2 into 1 ( Figure S5C ) in the presence of NADPH (see Supplemental Information). In control experiments, when assays were conducted in the absence of the NADPH or the enzyme NzsA or in the presence of 6, there were no turnovers ( Figure 5 ), confirming that NzsA catalyzes the installation of the hydroxyl group at C-11 position of 2 to yield 1, and the epoxy derivative 6 is a shunt product in the DnzsA mutant. NzsA was also incubated with (R)-streptoverticillin 4 and precarazostatin 5, but in both cases no formation of a new product, or disappearance of the starting material, was observed ( Figure 5 ). These observations strongly suggest that NzsA mediates the last enzymatic step in the biosynthesis of 1.
To further confirm the biotransformation from 5 to 1 in the NZS biosynthesis, in vitro reconstituted biotransformation was carried out. Upon incubation of 5 with the recombinant enzymes, NzsG and A, along with DMAPP, Mg
2+
, and NADPH (see Supplemental Information), we observed the formation of 1 and 2 as evidenced by the exact mass and the same HPLC retention time as the authentic 1 and 2 ( Figures S5D-S5E ).
DISCUSSION
Based on the bioinformatics analysis and the experimental data, we propose the biosynthetic pathway of 1 in MA37 as shown in Scheme 1. NzsB-F are likely to be involved in the precursor pathways. NzsB could be a housekeeping enzyme for tryptophan supply. NzsD resembles a family of PLP-dependent aromatic amino acid aminotransferases, suggesting its role in the conversion of L-tryptophan to indole-3-pyruvic acid. NzsC, a putative type I IPP isomerase, could be responsible for DMAPP supply (Berthelot et al., 2012) . NzsE is a putative acyl carrier protein (ACP), which presumably transfers malonyl-coenzyme A (CoA) into malonyl-ACP. Both NzsF and NzsJ are annotated as putative 3-oxoacyl-ACP synthases (KASIII). However, they share no significant sequence similarity with each other. While NzsJ bears no significant homology to characterized KAS III proteins, NzsF shares moderate sequence identity (37% identity and 55% similarity) to FabH from S. coelicolor A3(2) (Revill et al., 2001) , which catalyzes the condensation reaction between acetyl-CoA and malonyl-ACP to form acetoacetyl-ACP. It is postulated that NzsF is responsible for the formation of acetoacetyl-ACP using acetyl-CoA and malonyl-ACP as substrates, followed by reduction to generate 3-hydroxybutyryl-ACP.
We propose that NzsH could perform an acyloin coupling reaction between indole 3-pyruvate and pyruvate to generate a-ketoacid intermediate 7. The condensation reaction between 7 and 3-hydroxybutyryl-ACP could be mediated by the putative KASIII enzyme NzsJ via a reversible indole attack to yield 8. Decarboxylation-driven cyclization of 8 would result in an indole-fused cyclopentane intermediate 9, which could immediately undergo the ring rearrangement to generate an indole-fused cyclohexanone tricyclic intermediate 10, followed by dehydration and hydroxylation at C4 of 10, to generate 11. 11 would be readily tautomerized using positively charged nitrogen in the indole ring as the electron sink, followed by dehydration via base-catalyzed double-bond migration to furnish the ortho-quinone [b] indole tricyclic carbon backbone 12. Examination of the metabolite profile extracted from the culture of the DnzsG mutant allowed identification of an ion with m/z identical to that of 12 ( Figure S6 ). Although this compound could not be isolated, the mass is consistent with the structure of the predicted intermediate 12.
The enzyme(s) responsible for the formation of 12 remain to be confirmed. The formation of 12 may partially resemble the enzymatic reaction catalyzed by ScyC in the pathway of scytonemin (Balskus and Walsh, 2009 ). The dimeric alkaloid scytonemin is a cyanobacterial metabolite, functioning as a sunscreen (Balskus and Walsh, 2008) . In the case of scytonemin biosynthesis, ScyA, a ThDP-dependent enzyme, was found to be responsible for the acyloin coupling of indole-3-pyruvate and p-hydroxyphenylpyruvate to yield the b-ketoacid product (Balskus and Walsh, 2008) , which can then be cyclized and decarboxylated by the action of the unique enzyme, ScyC, to form the indole-fused cyclopentane intermediate (Balskus and Walsh, 2009) . It is hypothesized that NzsI could play a key role in this multistep biotransformation, as our in vivo results indicated that nzsI is essential for the production of 1. The exact roles of NzsH, J, and I in the biosynthesis of 1 is currently under investigation in our laboratories. 12 could further undergo reduction, followed by O-methylation, to yield the intermediate 5 and the shunt product streptovertillicin 4. The prenylation event on 5 occurs in the presence of NzsG and DMAPP to produce 2. The hydroxylation of 2 by NzsA finally provides 1. Our in vivo and in vitro results unambiguously demonstrated the enzymatic coupled reactions from 5 to 1, whereby the prenylation catalyzed by NzsG must occur prior to the NzsA-mediated hydroxylation (Figures 4 and 5) . When nzsA is inactivated, the DnzsA mutant also accumulates the epoxylated metabolite 6 via an unidentified epoxidase.
SIGNIFICANCE
Neocarazostatin A 1 is a potent free scavenging agent for protecting cell damage caused by free radicals. It possesses an intriguing tricyclic aromatic ring system, of which the chemical logic during the biosynthesis remains to be determined. We describe here the identification and characterization of the gene cluster for NZS biosynthesis in the soil bacterium Streptomyces sp. MA37 through in silico analysis, 
. Chemical Structures of Intermediates and Shunt Products Isolated from the Mutants in This Study
The structures of 2, 4, 5, and 6 were fully characterized by HR-ESIMS and 1D and 2D NMR spectroscopic analyses.
Figure 4. HPLC Analysis of the Reactions Catalyzed by NzsG at UV of 247 nm
Trace A shows the standard 5. Trace B shows the analysis of the conversion of 5 to 2 in a reaction containing Mg 2+ (5 mM), 5 (1 mM), NzsG (0.8 mg/ml), and 
DNA Sequencing and Analysis
The ORFs of the nzs gene cluster were deduced from the sequence by running the FramePlot 4.0 beta program (http://nocardia.nih.go.jp/fp4/). The corresponding deduced proteins were compared with other known proteins in the databases using BLAST (http://www.ncbi.nlm.nih.gov/blast/). Amino acid sequence alignments were performed with the ClustalW algorithm from BIOLOGYWORKBENCH 3.2 software (http://workbench.sdsc.edu). The phylogenetic tree was drawn using MEGA 6.0 (Tamura et al., 2013) . The sequence of the neocarazostatin biosynthetic gene cluster was identified from the sequenced genome via BLAST method using YerE as the sequence query. The neocarazostatins biosynthetic gene cluster was submitted to NCBI GenBank with the accession number NCBI: KP657980.
Extraction and Purification of Neocarazostatin A, Neocarazostatin B, (R)-Streptoverticillin, Precarazostatin, and 16,17-Epoxyneocarazostatin B Streptomyces sp. MA37 and its mutants were inoculated into ISP2 medium, and were grown for 2 days at 28 C and 200 rpm. The culture was then transferred into fresh ISP2 medium (1:100, v/v) and cultivated at 28 C and 200 rpm for 5 days. Mycelia were collected and resuspended in one-tenth of the original culture volume of acetone, and the suspension was ultrasonically disrupted using a KQ3200V Ultrasonic cleaning apparatus (40 kHz, 25 min). Cell pellets were eliminated by centrifugation, and supernatants were subsequently dried out by rotary evaporation. Meanwhile the culture supernatant was extracted by an equal volume of ethyl acetate twice. The organic phase was collected and evaporated to dryness. Residues from two extracts were combined and redissolved in 1/100th of original culture volume of methanol for HPLC or liquid chromatography-mass spectrometry (LC-MS) detection. Purification of the target compounds was performed by gel filtration (Sephadex G200) using methanol as the mobile phase. The corresponding sections were dried by rotary evaporation and dissolved in methanol, and were further purified by semipreparative HPLC on an Agilent ZORBAX SB-C18 column (5 mm, 9.4 3 250 mm) at a flow rate of 3 ml/min. The wavelength of the UV monitor was set at 247 nm. For the detection of neocarazostatin A, the mobile phase was 52:48 A/B (solvent A was 0.1% formic acid in ultrapure water and solvent B was 0.1% formic acid in CH 3 CN); for neocarazostatin B, the mobile phase was 42:58 A/B; for (R)-streptoverticillin, the mobile phase was 45:55 A/B; for precarazostatin, the mobile phase was 53 HPLC and Tandem MS Analysis HPLC analysis was carried out on a DIKMA Diamonsil C18 column (250 3 4.6 mm, 5 mm, column temperature 30 C) using a DIOEX P680 HPLC instrument. For fermentation analysis, samples were eluted with a gradient from 90:10 A/B to 60:40 A/B over 10 min, followed by another gradient to 45:55 A/B over 35 min at a flow rate of 1 ml/min, monitored by UV detection at 247 nm. For enzymatic analysis, samples were eluted with a gradient from 70:30 A/B to 0:100 A/B over 18 min, at a flow rate of 1 ml/min, and UV monitored at 247 nm. For carbazole, fluorene, phenazine, dibenzothiophene, acridine, Trp, IAA, IBA, and indole-3-pyruvic acid, samples were eluted with a gradient from 95:5 A/B to 0:100 A/B over 25 min, at a flow rate of 1 ml/min, and UV monitored at 220 nm for carbazole, fluorene, phenazine, dibenzothiophene, 392 nm for acridine, and 280 nm for Trp, IAA, IBA, and indole-3-pyruvic acid. Twenty percent of the eluent was injected to source and 80% to waste during LC-MS analysis. Solvent A was 0.1% formic acid in ultrapure water and solvent B was 0.1% formic acid in CH 3 CN. The same column and LC gradient were used in all LC-MS analyses. High-resolution MS analysis, which consisted of a full scan in positive mode followed by a data-dependent Trace A shows the analysis of the conversion of 2 to 1 in a reaction containing 2 (1 mM), NzsA (1 mg/ml), spinach ferredoxin (100 mg/ml), spinach ferredoxin-NADP+ reductase (0.2 U/ml), NADPH (1.0 mM), glucose-6-phosphate (10 mM), and glucose-6-phosphate dehydrogenase (10 U/ml) in a Tris-HCl buffer (50 mM, pH 7.5). Trace B shows the standard 2. Traces C-E show the analyses of reactions containing NADPH, NzsA (1 mg/ml) and various substrates, indicating that only 2 is the substrate for NzsA.
fragmentation scan, was performed on a Thermo Scientific LTQ XL Orbitrap mass spectrometer equipped with a Thermo Scientific Accela 600 pump.
NMR Analysis
NMR spectra of neocarazostatin B 2 (8.5 mg), (R)-streptoverticillin 4 (7 mg), precarazostatin 5 (4.3 mg), and 16,17-epoxyneocarazostatin B 6 were recorded on Agilent 600-MHz instrument in CD 3 OD. NMR analyses of neocarazostatin A 1 were recorded on Varian 600-MHz spectrometer in CD 3 Cl.
Structural Elucidation of Neocarazostatin A 1 HR-ESIMS analysis of 1 established a molecular formula of C 22 H 27 NO 4 . Dereplication using Antibase (Laatsch, 2013) suggested that this compound could be a known metabolite, neocarazostatin A, previously isolated from Streptomyces sp. GP38 (Kato et al., 1991) . 1 also showed a characteristic UV pattern, with absorption maxima at 229, 249, 271, 292, 331, and 345 nm. To confirm the structure, we obtained a complete set of 1D and 2D NMR spectral data. The structure of 1 was finally established through comparison of 1 H and 13 C NMR spectra data with those previously reported, which unambiguously confirms that 1 is neocarazostatin A.
In-Frame Deletion of nzsA to nzsH To inactivate nzsA, we amplified a 2,030-bp upstream fragment and a 2,002-bp downstream fragment from genomic DNA of Streptomyces sp. MA37 by PCR using the primers N-2-up-F/N-2-up-R and N-2-do-F/N-2-do-R, respectively (Table S3) . PCR was performed in 20 ml volume with 5% DMSO and KOD DNA polymerase (Toyobo). The amplification conditions were: initial denaturation at 95 C for 5 min; 30 cycles of denaturation at 95 C for 30 s, annealing at 58 C for 30 s, and extension at 68 C for 2 min; and gap infilling at Dashed line: proposed reactions. Solid line: reactions were confirmed biochemically. C for 10 min. The obtained fragments were cloned into the HindIII/EcoRI site of pKC1139 by using the In-fusion HD Cloning Kit (Clontech) to obtain the in-frame deletion vector construct, which was then transferred into Streptomyces sp. MA37 via E. coli-Streptomyces conjugation. Following a previously published procedure (Yu et al., 2009) , the nzsA in-frame deletion mutant strains were identified by screening out and designated as WDY633. The same strategy was used to construct nzsB to nzsJ in-frame deletion mutants, except that different primers were used to amplify the left and right arms of the target genes (Table S3 ). The in-frame deletion mutant strains of nzsB to NzsJ were designated as WDY640, WDY641, WDY642, WDY644, WDY646, WDY638, WDY630, WDY648, and WDY635, respectively (Table S1 ).
Complementation of the Mutant Strains WDY633, WDY644, WDY646, WDY638, WDY630, WDY648, and WDY635 To complement WDY633, a 1,257-bp fragment that contains the whole nzsA gene sequence was amplified from genomic DNA of Streptomyces sp. MA37 by high-fidelity PCR using the primers N-1-HB-F and N-1-HB-R (Table  S3 ). The amplification conditions were: initial denaturation at 95 C for 5 min; 30
cycles of denaturation at 95 C for 30 s, annealing at 58 C for 30 s, and extension at 68 C for 1 min; and gap infilling at 68 C for 10 min. The obtained fragment was cloned into the NdeI/EcoRI site of pIB139, which can integrate into Streptomyces chromosome via the VC31 phage site. The construct obtained was then transferred into Streptomyces sp. MA37 in-frame deletion mutant via E. coli-Streptomyces conjugation. Following the procedure described previously (Kieser et al., 2000) , the DnzsA complementation mutant strain was identified by screening out and designated as WDY634. The same strategy was used to complement WDY644, WDY646, WDY638, WDY630, WDY648, and WDY635, except that different pairs of primers were used for each complementation construct (Table S3 ). The complementation mutant strains of DnzsE, DnzsF, and DnzsG-J were identified by screening out and designated as WDY645, WDY647, WDY639, WDY631, WDY649, and WDY636, respectively.
Construction of NzsA and NzsG Overexpression Vector
To overexpress NzsA, we amplified a 1,257-bp fragment that contains the whole nzsA from genomic DNA of Streptomyces sp. MA37 by PCR using the primers NzsA_F/NzsA_R (Table S2) . PCR was performed in 20 ml volume with 5% DMSO and KOD DNA polymerase (Toyobo). The amplification conditions were: initial denaturation at 95 C for 5 min; 30 cycles of denaturation at 95 C for 30 s, annealing at 58 C for 30 s, and extension at 68 C for 90 s;
and gap infilling at 68 C for 10 min. The obtained fragments were cloned into the KpnI/XhoI site of pHS_SUMO (Lv et al., 2015) using the In-fusion HD Cloning Kit (Clontech) to yield the overexpression construct pWDY651. The same strategy was used for nzsG cloning, except that the primers NzsG_F/ NzsG_R were used for amplification (Table S3 ). The NzsG overexpression construct was designated pWDY650.
Expression and Purification of NzsA and NzsG
The protein expression constructs pWDY638 and pWDY639 were individually transformed into E. coli BL21 (lDE3) (Novagen) competent cells. Single colonies from each transformation were inoculated to a starter culture (5 ml of super optimal broth [SOB] medium containing 50 mg/ml kanamycin) and cultivated at 37 C and 200 rpm. When the A 600 of the medium reached 0.5, the culture was transferred to 500 ml of fresh SOB medium and incubated at 37 C, 200 rpm. Isopropyl b-D-1-thiogalactopyranoside was added to a final concentration of 1 mM when the A 600 reached 0.6. After overnight culture at 16 C, cells were harvested by centrifugation and frozen at À40 C. All subsequent steps were performed at 4 C. After thawing on ice, cells were suspended in lysis buffer (200 mM Tris-HCl [pH 8.0], 500 mM NaCl, and 10 mM imidazole). The cell suspension was lysed with a Nano Homogenize Machine (AH100B; ATS Engineering). To separate the cellular debris from the soluble protein, the lysate was centrifuged at 20,000 3 g at 4 C for 20 min. The supernatant was incubated with 1.5 ml Ni-Sepharose 6 Fast Flow (GE Healthcare) which had been pre-equilibrated with equilibration buffer (200 mM Tris-HCl [pH 8.0], 500 mM NaCl, and 10 mM imidazole) for 2 hr at 4 C. The resin was washed with 5 ml of the equilibration buffer, followed by twice washing with buffer containing 25 mM imidazole. The recombinant protein was eluted with 5 ml of wash buffer containing 250 mM imidazole. The eluted recombinant proteins were concentrated to 2.5 ml using Centrifugal Filter Units (Millipore Regenerated Cellulose 3,000 molecular weight cutoff). The samples were then desalted by PD-10 Columns (GE Healthcare) according to the manufacturer's instruction. The cleavage of the SUMO tag of the eluted recombinant proteins was conducted using SUMO Protease (Invitrogen, catalog #12588-018) in buffer composed of 50 mM Tris-HCl (pH 8.0) and 150 mM NaCl at 4 C for 4 hr. The SUMO tag and SUMO Protease were finally removed from the cleavage reaction by using 0.5 ml of Ni-Sepharose 6 Fast Flow (GE Healthcare). The purified protein was stored at À80 C in storage buffer (50 mM TrisHCl [pH 8.0], 150 mM NaCl, 10% [w/v] glycerol, and 1 mM DTT).
NzsG Activity Assay
The enzyme assay of NzsG was carried out in 50 mM Tris-HCl buffer (pH 7.5) with 5 mM MgCl 2 , containing 0.8 mg/ml NzsG, 1 mM substrate, and 0.2 mM DMAPP, in a final volume of 50 ml. The optimal assay conditions were obtained at 30 C. After 30 min, the reaction was quenched by the addition of two equal volumes of methanol and mixed by vortexing. The mixture was centrifuged at 15,000 rpm for 20 min to remove protein. The supernatant was then subjected to LC-tandem MS (MS/MS) analysis under the same conditions as described above.
Kinetic Studies of NzsG
Optimization of NzsG in vitro assays is described in the legend of Figure S4D . The enzyme assays of NzsG were performed in a mixture (total volume 50 ml) containing 50 mM Tris-HCl (pH 8.0), 5 mM Mg 2+ , 1 mM DMAPP, 1 mM DTT, and 0.087-3 mM precarazostatin 5 at 30 C for 10 min. Reactions were initiated by the addition of enzyme (0.5 mM NzsG). An equal volume of methanol was added to quench the reaction and remove proteins by centrifugation. The supernatant was analyzed by HPLC. Kinetic analyses of NzsG reactions were carried out as described in the legend of Figure S4F .
NzsA Activity Assay Enzyme assay of NzsA activity was carried out on a 50-ml scale with substrates (1 mM), NzsA (1 mg/ml), spinach ferredoxin (100 mg/ml), spinach ferredoxin-NADP + reductase (0.2 U/ml), NADPH (1.0 mM), glucose-6-phosphate (10 mM), and glucose-6-phosphate dehydrogenase (10 U/ml) in Tris-HCl buffer (50 mM, pH 7.5). After incubation at 30 C for 30 min, the reaction was quenched by the addition of two equal volumes of methanol and mixed by vortexing. The mixture was centrifuged at 15,000 rpm for 20 min to remove protein. The supernatant was then subjected to LC-MS/MS analysis under the same conditions as described above.
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